Leonard S. Schleifer - Mar 31, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
President & CEO, Director
Signature
/s/**Leonard S. Schleifer
Stock symbol
REGN
Transactions as of
Mar 31, 2022
Transactions value $
-$2,049,089
Form type
4
Date filed
4/4/2022, 04:03 PM
Previous filing
Nov 19, 2021
Next filing
Apr 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$2.05M -2.89K -13.63% $710.01 18.3K Mar 31, 2022 By Trust F1, F2
holding REGN Common Stock 466K Mar 31, 2022 Direct
holding REGN Common Stock 200K Mar 31, 2022 2021 GRAT
holding REGN Common Stock 5.87K Mar 31, 2022 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 2,886 shares of Company stock on March 31, 2022 at prices ranging from $710.00 to $710.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 31, 2022 at each separate price.